Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Multi-center Study to Measure Inhaled Flow Rates Generated by Non-CF Bronchiectasis Patients for the T-326 Inhaler

NCT02563197 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02563197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02563197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Multi-center Study to Measure Inhaled Flow Rates Generated by Non-CF Bronchiectasis Patients for the T-326 Inhaler
Lead sponsor
Bayer
Phase
Phase 1
Overall status
Completed
Start date
November 23, 2015
Completion date
April 29, 2016
Enrollment
33 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis